Matches in SemOpenAlex for { <https://semopenalex.org/work/W4255668840> ?p ?o ?g. }
Showing items 1 to 63 of
63
with 100 items per page.
- W4255668840 abstract "PURPOSE: Pretreatment prostate-specific antigen (PSA) dynamics (PSA velocity and PSA doubling time) are widely advocated as useful prognostic markers in prostate cancer. We aimed to assess the published evidence for the clinical utility of PSA dynamics in this population.METHODS: We conducted a systematic review of studies published before March 2007 in which a PSA dynamic (velocity or doubling time) was calculated in patients before definitive treatment, a subsequent event (such as biopsy or recurrence) was ascertained, and the association between the two was analyzed. Our principal end point was the type of analysis reported, particularly whether the predictive accuracy of a statistical model that included both absolute PSA level and a PSA dynamic was compared with that of a model that included only PSA.RESULTS: Eighty-seven articles were eligible for analysis. The most common end points were biopsy (42 articles), and either recurrence (14 articles) or metastases or death (14 articles) after definitive therapy. Although PSA dynamics were generally found to be associated with outcome, only one article compared predictive accuracy of models with and without a PSA dynamic: this reported that PSA velocity improved prediction slightly (from 0.81 to 0.83), but was subject to verification bias. No article used decision analytic methods to examine the clinical impact of PSA dynamics.CONCLUSION: There is little evidence that calculation of PSA velocity or doubling time in untreated patients provides predictive information beyond that provided by absolute PSA level alone. We see no justification for the use of PSA dynamics in clinical decision making before treatment in early-stage prostate cancer. PMID: 19064972 Funding information This work was supported by: NCI NIH HHS, United States Grant ID: P50-CA92629" @default.
- W4255668840 created "2022-05-12" @default.
- W4255668840 creator A5030105260 @default.
- W4255668840 date "2009-06-15" @default.
- W4255668840 modified "2023-09-28" @default.
- W4255668840 title "Faculty Opinions recommendation of Systematic review of pretreatment prostate-specific antigen velocity and doubling time as predictors for prostate cancer." @default.
- W4255668840 doi "https://doi.org/10.3410/f.1162157.622627" @default.
- W4255668840 hasPublicationYear "2009" @default.
- W4255668840 type Work @default.
- W4255668840 citedByCount "0" @default.
- W4255668840 crossrefType "dataset" @default.
- W4255668840 hasAuthorship W4255668840A5030105260 @default.
- W4255668840 hasBestOaLocation W42556688401 @default.
- W4255668840 hasConcept C121608353 @default.
- W4255668840 hasConcept C126322002 @default.
- W4255668840 hasConcept C126894567 @default.
- W4255668840 hasConcept C143998085 @default.
- W4255668840 hasConcept C185592680 @default.
- W4255668840 hasConcept C202751555 @default.
- W4255668840 hasConcept C2775934546 @default.
- W4255668840 hasConcept C2779974597 @default.
- W4255668840 hasConcept C2780192828 @default.
- W4255668840 hasConcept C2781406297 @default.
- W4255668840 hasConcept C2908647359 @default.
- W4255668840 hasConcept C29456083 @default.
- W4255668840 hasConcept C48900799 @default.
- W4255668840 hasConcept C512399662 @default.
- W4255668840 hasConcept C55493867 @default.
- W4255668840 hasConcept C71924100 @default.
- W4255668840 hasConcept C99454951 @default.
- W4255668840 hasConceptScore W4255668840C121608353 @default.
- W4255668840 hasConceptScore W4255668840C126322002 @default.
- W4255668840 hasConceptScore W4255668840C126894567 @default.
- W4255668840 hasConceptScore W4255668840C143998085 @default.
- W4255668840 hasConceptScore W4255668840C185592680 @default.
- W4255668840 hasConceptScore W4255668840C202751555 @default.
- W4255668840 hasConceptScore W4255668840C2775934546 @default.
- W4255668840 hasConceptScore W4255668840C2779974597 @default.
- W4255668840 hasConceptScore W4255668840C2780192828 @default.
- W4255668840 hasConceptScore W4255668840C2781406297 @default.
- W4255668840 hasConceptScore W4255668840C2908647359 @default.
- W4255668840 hasConceptScore W4255668840C29456083 @default.
- W4255668840 hasConceptScore W4255668840C48900799 @default.
- W4255668840 hasConceptScore W4255668840C512399662 @default.
- W4255668840 hasConceptScore W4255668840C55493867 @default.
- W4255668840 hasConceptScore W4255668840C71924100 @default.
- W4255668840 hasConceptScore W4255668840C99454951 @default.
- W4255668840 hasLocation W42556688401 @default.
- W4255668840 hasOpenAccess W4255668840 @default.
- W4255668840 hasPrimaryLocation W42556688401 @default.
- W4255668840 hasRelatedWork W1970400785 @default.
- W4255668840 hasRelatedWork W1979374145 @default.
- W4255668840 hasRelatedWork W2068509057 @default.
- W4255668840 hasRelatedWork W2085683046 @default.
- W4255668840 hasRelatedWork W2099948048 @default.
- W4255668840 hasRelatedWork W2102167265 @default.
- W4255668840 hasRelatedWork W2108412422 @default.
- W4255668840 hasRelatedWork W2148869351 @default.
- W4255668840 hasRelatedWork W2607442245 @default.
- W4255668840 hasRelatedWork W3082324229 @default.
- W4255668840 isParatext "false" @default.
- W4255668840 isRetracted "false" @default.
- W4255668840 workType "dataset" @default.